Sandra Levy
ARTICLES BY THIS AUTHOR
- 5/31/2021
Alkermes receives FDA nod for Lybalvi
Alkermes' Lybalvi provides a treatment for adults with certain mental disorders, including schizophrenia and bipolar I. - 5/31/2021
Sandoz offers generic Remodulin for subcutaneous administration
The introduction of the RG 3-ml Medication Cartridge has enabled subcutaneous administration of Sandoz's treprostinil injection for the first time. - 5/31/2021
Glenmark intros generic Banzel
Banzel tablets had a market value of $285.3 million for the 12-month period ended April 2021, according to IQVIA. - 5/31/2021
Moderna applies for full FDA approval of its COVID-19 vaccine
Moderna's mRNA vaccine is currently on the U.S. market under an emergency use authorization, which was granted by the Food and Drug Administration in December. - 5/31/2021
Hikma debuts labetalol hydrochloride in dextrose injection, sodium chloride injection
Labetalol HCl injection, 100 mg/20 ml and 200 mg/40 ml vial had a market value of approximately $6 million in the 12 months ended March 2021, according to IQVIA. - 5/31/2021
AAM releases ‘Voices of Access’ report
The report from the Association for Accessible Medicines highlights the impact that accessible generic and biosimilar medicines have had on patients nationwide. - 5/31/2021
Hy-Vee offering COVID-19 vaccine incentives
The retailer is offering a $10 gift card to those who complete their COVID-19 vaccination at one of its pharmacies or pop-up vaccination clinics. - 5/31/2021
NACDS, NCPA laud Texas law regulating PBMs
Texas House Bill 1763 ensures fair and adequate reimbursement for all pharmacies. - 5/27/2021
Zydus Cadila launches biosimilar Ujvira
The launch marks the world’s first biosimilar antibody drug conjugate of trastuzumab emtansine. - 5/27/2021
Foresee Pharmaceuticals receives FDA nod for Camcevi
Camcevi 42 mg subcutaneous injection is a gonadotropin-releasing hormone agonist indicated for the treatment of adult patients with advanced prostate cancer.
